Senzime AB (Sweden) Insiders
| SEZI Stock | SEK 5.76 0.08 1.37% |
Senzime AB employs about 18 people. The company is managed by 7 executives with a total tenure of roughly 18 years, averaging almost 2.0 years of service per executive, having 2.57 employees per reported executive. Breaking down Senzime AB's management performance can provide insight into the firm performance.
| Anders Selin Insider VP Sales |
| Johanna Tulkki Insider COO CTO |
Senzime |
Senzime AB Management Team Effectiveness
The company has return on total asset (ROA) of (0.2949) % which means that it has lost $0.2949 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6434) %, meaning that it generated substantial loss on money invested by shareholders. Senzime AB's management efficiency ratios could be used to measure how well Senzime AB manages its routine affairs as well as how well it operates its assets and liabilities.Senzime AB Workforce Comparison
Senzime AB is rated second in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 428. Senzime AB holds roughly 18.0 in number of employees claiming about 4% of equities under Health Care industry.
Senzime AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Senzime AB Price Series Summation is a cross summation of Senzime AB price series and its benchmark/peer.
Senzime AB Notable Stakeholders
A Senzime AB stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Senzime AB often face trade-offs trying to please all of them. Senzime AB's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Senzime AB's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Catrin Molund | Business Development Director | Profile | |
| Anders Selin | VP Sales | Profile | |
| Johanna Tulkki | COO CTO | Profile | |
| Rianne Waninge | Application Scientist | Profile | |
| Pia Renaudin | Chief Officer | Profile | |
| Anders Jacobson | Chief Technical Officer | Profile | |
| Slavoljub Grujicic | Chief Officer | Profile |
About Senzime AB Management Performance
The success or failure of an entity such as Senzime AB often depends on how effective the management is. Senzime AB management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Senzime management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Senzime management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Senzime AB develops patient-oriented monitoring systems that assess patients biochemical and physiological processes before, during and after surgery in Sweden. Senzime AB was founded in 1997 and is based in Uppsala, Sweden. Senzime AB is traded on Stockholm Stock Exchange in Sweden.
Please note, the imprecision that can be found in Senzime AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Senzime AB. Check Senzime AB's Beneish M Score to see the likelihood of Senzime AB's management manipulating its earnings.
Senzime AB Workforce Analysis
Traditionally, organizations such as Senzime AB use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Senzime AB within its industry.Senzime AB Manpower Efficiency
Return on Senzime AB Manpower
| Revenue Per Employee | 610K | |
| Revenue Per Executive | 1.6M | |
| Net Loss Per Employee | 4.6M | |
| Net Loss Per Executive | 11.7M | |
| Working Capital Per Employee | 888.9K | |
| Working Capital Per Executive | 2.3M |
Additional Tools for Senzime Stock Analysis
When running Senzime AB's price analysis, check to measure Senzime AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senzime AB is operating at the current time. Most of Senzime AB's value examination focuses on studying past and present price action to predict the probability of Senzime AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senzime AB's price. Additionally, you may evaluate how the addition of Senzime AB to your portfolios can decrease your overall portfolio volatility.